SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?


To: arnie h who wrote (1851)6/9/2005 8:48:04 AM
From: Robohogs  Read Replies (1) | Respond to of 2173
 
Look at SEPR - drug one of fastest launches ever and the press/shorts make it seem to be an over-hyped bust. The easy game now is to spread disinformation and short companies launching new drugs. AMLN, SEPR, ICOS, LGND, some of the cancer stocks, . . . Besides if all goes well, maybe the drug will kill people (ELN).

Jon